Share this page!

🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Twitter logo
Aug 23 • 4 tweets • 3 min read
Dr. Keyoumars Ashkan #DrKeyoumarsAshkan Surgeon & professor, and he also ran the European trials for #DCVaxL from $NWBO
Professor Ashkan performs life-saving awake brain tumour surgery while patient plays violin! via @YouTube
$NWBO #DCVaxL #Glioblastoma Phase 3 trial results presented by #DrKeyoumarsAshkan

#DrLindaLiau discusses how they brain map at UCLA to preserve the talents of Los Angeles creatives who need brain surgery, frequently for GBM.

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with 🇺🇸🤝🇺🇦eastvillagetwt

🇺🇸🤝🇺🇦eastvillagetwt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @eastvillagetwt

🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Aug 23
Northwest Biotherapeutics Announces -

Approval of Pediatric Investigation Plan (PIP) by MHRA

#DCVaxL $NWBO newsfilter.io/a/8ae27d3f0428…
“The development, regulatory review and regulatory approval of a PIP is a pre-requisite for application for approval of a new medicine for adult patients, such as DCVax®-L.”
“The Company submitted its proposed PIP to the MHRA in February 2022, and has been going through the regulatory review process since then.  On August 17, the Company received final approval of the PIP from the MHRA.”
Read 9 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
May 13
$NWBO DEDUCED RECKONING: Northwest Bio reports Phase 3 results.

#DCVaxL
@joanlappin

finance.yahoo.com/news/deduced-r…
1/ "Only 5% of glio patients survive for five years. So how stunning is it for DCVAX-L to see life expectancy at 60 months rise from 5.7% to 13%, an increase of 228%. Some patients have seen total remission glio and are cancer free more than a decade after treatment.
2/ For example, Brad Silver participated in the Phase 1 trial 17 years ago and is cancer free now."

Read 81 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
May 11
DCVax-L Phase 3 Trial Results

Final Top Line Results, Phase 3.

Delivered 5/10/22 to the New York Academy of Sciences by

Dr. Paul Mulholland, MBBS, MSc, PhD, FRCP, University College Hospital, UK

#DCVaxL $NWBO #TLD

via @YouTube
If you watch this by idea closely, you’ll note that the trial coins not proceed ethically UNLESS it was a crossover style. But all the patients lived longer including the recurrent ones who got access to #DCVaxL late. THAT was their placebo arm originally. There is no way in hell
, in my opinion, that a regulator is going to push a drug company into a crossover trial ethically, and then say, oh, man, your drug is so successful in making everyone live longer, but there is nothing that can be done. You fail! That’s not how regulation works.
Read 9 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Mar 17
Chinese plot to smear US Congress hopeful unveiled

bbc.com/news/60773595
MI5 warning over 'Chinese agent' in Parliament

bbc.com/news/uk-politi…
Refugees Are Victims of Chinese Espionage, Not Accomplices

A Tibetan case reveals how the Chinese Communist Party coerces communities worldwide.

foreignpolicy.com/2021/01/05/ref…
Read 4 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Oct 14, 2020
1/ $ATHX SMBC NIKKO SECURITIES AMERICA, INC.
2/ Equity Research: Athersys, Inc. (ATHX)

USA/Biotechnology 12-October-2020

Target Price Outperform $11.00

Up/Downside: 469.9% - Reiterate Outperform

smbcnikko.bluematrix.com/docs/pdf/bf377…

Quoting short summary:

“We caught up with management ahead of several catalysts expected in 1H21.
3/ In our view, recent share price weakness has mostly stemmed from lack of near-term catalysts. However, investors accumulating now are likely to benefit from positive news flow through mid-2021, leading to a rerating of shares.
Read 10 tweets
🇺🇸🤝🇺🇦eastvillagetwt Profile picture
Sep 21, 2020
These reports seem a bit backwards. The banks are not police agencies. They are reporting these transactions SO THAT if it is illegal, which might be the case, the govt investigates.

Banks Suspected Illegal Activity, but Processed Big Transactions Anyway nytimes.com/2020/09/20/bus…
They are saying, hey, we do not know for sure, we are not spies on our customers and are not police, but you should look into this and tell us to stop, if it is actually illegal.

Apparently they file and FinCen never does anything. It’s also possible FinCen wants to spy.
If that is the case, then the reports allow FinCen to follow money trails and figure out who is involved. Banks stopping it actually shuts down the info flow.

The question is, does the government then ever actually do anything about these reports? That is a subtler question.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(